Clinical Trial Update: A Phase 2 Study to Evaluate Pharmacodynamics of YKP10811 in Patients With Chronic or Functional Constipation [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamics study of YKP10811 in chronic constipation and functional constipation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Functional Constipation

Drugs mentioned

• YKP10811

Snippet

Sponsor: SK Life Science, Inc. | Conditions: Chronic Constipation, Functional Constipation | Phase 2 | Status: COMPLETED